Kintor Pharma sets Hong Kong IPO in motion

pills adobe stock 575x375 pharmaceuticals
By Jonathan Breen
12 May 2020

China-based Kintor Pharmaceutical has kicked off bookbuilding for its Hong Kong listing, the latest in a stream of healthcare IPOs in the city. The issuer is targeting HK$1.86bn ($240.1m) in proceeds.

Huatai Financial, the sole sponsor and a joint global co-ordinator alongside CICC and UBS, began taking orders for the offering on Tuesday in Hong Kong.

The trio, alongside five other bookrunners, are marketing a float of 92.3m shares with price guidance of HK$17.80 to HK$20.15 a share. The ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial